Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 09, 2025
Andelyn Biosciences has partnered with Jaguar Gene Therapy to perform late-stage Process Performance Qualification (PPQ) manufacturing of JAG201, an investigational gene therapy targeting SHANK3 haploinsufficiency which is clinically diagnosed as ...
read more
Thursday, February 29, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform for several programs under the ...
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
Tuesday, November 13, 2018
Angion Biomedica and Sinovant Sciences announced a collaboration and license agreement for BB3, Angion's investigational small molecule mimetic of hepatocyte growth factor (HGF), China, Hong Kong, Macau, and Taiwan.
read more
ANGUS Chemical Company, a manufacturer and marketer of nitroalkanes and their derivatives, has announced the launch of its new life sciences division, ANGUS Life Sciences.
read more
Tuesday, February 15, 2022
ANGUS Chemical Company, a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the expansion of its Sterlington, Louisiana manufacturing facility to include commercial production of...
read more
ANGUS Chemical Company unveiled a new name and logo as part of an extensive corporate rebranding initiative.
read more
Thursday, October 14, 2021
ANGUS Chemical Company announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO™ tromethamine buffers. ANGUS is the world's largest and only fully integrated original manufacturer of TRIS AMINO buffers, which are ...
read more
ANI Pharmaceuticals has acquired ANDAs for 23 previously marketed generic drug products from IDT Australia, Ltd. for $2.6 million and a limited single-digit royalty for one product.
read more
ANI has received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
ANI announced the receipt of clinical data on Cortrophin® Gel from a study that evaluated the blood-level cortisol response in a 20-person healthy volunteer population.
read more
Monday, November 22, 2021
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, ...
read more
ANI has completed the acquisition of a portfolio of six generic products, related manufacturing and supply agreements from Amneal and Impax for cash consideration of $2.3 million.
read more
Tuesday, January 07, 2014
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling.") The ...
read more
Monday, November 04, 2019
ANI Pharmaceuticals announced the launch of its new CDMO brand, ANI Global Source. This action follows the integration of WellSpring Pharma Services, acquired one year ago.
read more